{"name":"Rare Disease Research, LLC","slug":"rare-disease-research-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOcHRtNG9BTlRTOUxXUU1oS2ZwVTh0ZVVKcG1mSEJ0UjZHRF9wU0VjeEpFR2JDTUFwMGROZ1d4V2szckVsQkliSE5DeE80RmJEd2pSSnRLbHZKUXNsSUNTRHRSWEc2MENlU21aNXB2VlFJSWc3bC1UZ2dzOThJbk1ZX1ZJdUVLM0N6ZVJUOHVJdkx3WE9hOXo4MUVuRU9Qa0NSdTdmTGxmUUstMm50QmhRTFJ0azhHdG5SQmhsaTRaMy1YdUthTHk1Wg?oc=5","date":"2026-04-06","type":"pipeline","source":"Quiver Quantitative","summary":"BioCryst Pharmaceuticals Appoints Dr. Sandeep M. Menon as Chief Research and Development Officer - Quiver Quantitative","headline":"BioCryst Pharmaceuticals Appoints Dr. Sandeep M. Menon as Chief Research and Development Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQWU9uWGhsYXJkYmt0TFBpOUdpam42MEtld0p0dmxJR1VJZmFyZHNtcXRsYmE5S3BoaHlrZFl0MTh5MWNPblJ5RjdWQ3h2dU1MRXdSLUxsUlBXb3FfdEt4UUIwMmJ4R1pCb2kwOHFNZmZfdjlPcFB5MVJGcVh2RUZ2c1VxRVNYWTU5RFo2NE1DejhPSXpDMVFnN0thMWZ3TGpvUXlWdGZRU2QzSjZTR2ZkbERCempCb2M?oc=5","date":"2026-03-25","type":"regulatory","source":"Fierce Pharma","summary":"FDA approves Denali's Hunter syndrome drug, handing rare disease community a win - Fierce Pharma","headline":"FDA approves Denali's Hunter syndrome drug, handing rare disease community a win","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPNnhtUG13YlQzMTJweDBNYzJqaG9qV2F0Q3kwdjdFNTJ3RFdBZm9scEN4ZFcxREE0ZmFWQlZlS285djd6bGJXcDk2ZVVHTVFBaHRLd09EOTJMM3JkR1NsNHF4VHk1SHEwcXlFME5oclBCaU50MnY2NFVfZFF5SG9kY2ZkMTBHM052X2VtaVhoZng1cTZ6WU05V0lndDA5VVhoSHpBb19UU2g1YUhZcTdZVFJyaDhSZk5X?oc=5","date":"2026-02-18","type":"pipeline","source":"PharmaLive","summary":"Rare Disease Day 2026: Phesi CEO says digital twins offer new avenues of hope for patients - PharmaLive","headline":"Rare Disease Day 2026: Phesi CEO says digital twins offer new avenues of hope for patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOLWdCMlRmY3loM3p1SkVoSGtGemc1N1hScDZORkRWTFdNSGhVREMxQ2lxdlFkVzJWYTVrdlNEd242dlN3ZW1teUJfUjRER0t6SnBteldlM3dvY05hQTA2REU3Y2ZLR3BkSy1GRVNMLUkwMkZ1OGx3eGM4WTZydDdIeHhIUGs5aTlxWk13Tk03ZzdybmdrM3l2LS1adWhEZw?oc=5","date":"2026-02-10","type":"pipeline","source":"Inside Philanthropy","summary":"New Wins for Rare Disease Research, Funded by Philanthropy - Inside Philanthropy","headline":"New Wins for Rare Disease Research, Funded by Philanthropy","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-16","type":"pipeline","source":"CNBC","summary":"Making U.S. biotech more competitive with China's could help rare disease patients, experts say - CNBC","headline":"Making U.S. biotech more competitive with China's could help rare disease patients, experts say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNZDI5RGVHNC1hYk9aR05xWFlpZUNrakVrUmNrT010aEgzZnk5YjI2eWd0Q3pBQTZla3gwU24wQTZDdDRXT2xUd3FSNkRaSDRqZzNxWlN3R1ZjdTlRbWhFSTctTzRTQzVIcEgxN0RMcTN5ZWJtMUt3QnFIbXR4UnJOakM2QUY2NUxRdTEwQ2xJa3k3SktxUFo4Z1FXVUR3ckszTHB2TmhqNkV0clphajJMR0JIaVJWQXVITlpYQWVpLU1KVC1DT0N0Y2oyUzhvVVU0dmg1c1kydjFJdE0wN0M4cGhrRi1KLUozZHhsdHpJUXhnOHhTRGFzNGlwbnJJWWNvMTJ6SEUyTDBfWUdoNGttbWtydFlKWTVWUE9mTnNpd0lSSkloTURQVHVfNkdJbFk?oc=5","date":"2025-12-22","type":"pipeline","source":"businesswire.com","summary":"Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA - businesswire.com","headline":"Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNczluOVNqOXJ6RW1HTDRxeUxQREY0VUtfR0ZrT09BZ09IT2pqbklpR1Z1OEozX2taZWFPQzdQaktydk5MY1dWRHUwU0RrODNiNEg3Vm52eXkzSzNfbzdDdWxLZ0s4Yng3dVIyNGE5Y0ZQUWgtMGNoM3ZuMS0yVmNNYXlYRWFCeTVXVERPNzE5elZLSzZjdUwyWno3TlJzWUxERnVWaXR1czdoLU5UVVl3UTlqWVItWUwxZHNuSkVn?oc=5","date":"2025-12-09","type":"pipeline","source":"kalkinemedia.com","summary":"Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research - kalkinemedia.com","headline":"Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-17","type":"pipeline","source":"GlobeNewswire","summary":"Rani Therapeutics Announces up to $1.085 Billion - GlobeNewswire","headline":"Rani Therapeutics Announces up to $1.085 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOM3paU0FTUU1KY3poc0ZkZUJ5SW1pWnlEOWl1MU90MXhzNlFpQ1J2UlVOejQySHJSNkYyVWliZTRmMjIyejlzNXV2UVRqeXo0SnRpRk5tMnJnMDFCenBtQnBWMXVibXZzcXdYRFBNbWhKSV9PbkgxSFc2UDB3ekIxYUg0VzNfa3RPWm9pbHYydFBwSlF6UGJhMHktbUlBbXZwZEtFMncwR0dDdl9pNXRaWjFtWTByMFZLM0hsUTZQemh2NU5rVTM5ZmxOZEVrWmFHWUE?oc=5","date":"2025-10-06","type":"trial","source":"Fierce Pharma","summary":"Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials - Fierce Pharma","headline":"Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOTFFERExJa3E5UkNDN1d6MFE0V1RaeFA5akRDOWwtdkpBbnVXb1UzbkVFU2dxOUJnOUR1S2xPZXlPdVBqeDlqTTFjaEF2S2pULWNGSGpnVHhnbjEyZ0ZyZlhNMHVJVEJ4ekduN25MdGlZZDd4WUwzLXBLQW1qZ2tWVXpFOUROcDhyQVdSS2RLcWdSM3pVSWl4Y2RpRXhxWjV4VmlkbnJVMnRTLTIzd25nMG5CLXZlb1B0OHVIaDFDZm1YS2xpZ2hxc3MyUFk5dm5tM213a0ExSU5YYzJiTTZQdGFrOA?oc=5","date":"2025-08-08","type":"pipeline","source":"Proactive financial news","summary":"Inside Biotech: US orphan drug policy a silver lining for rare disease research - Proactive financial news","headline":"Inside Biotech: US orphan drug policy a silver lining for rare disease research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQbG81cFYtM0RobjVOdHM5Yy1XeUsxYmR3Z0hTSHlBVVZzcnJNMHZUSUwtRlJnWDVJYmtVTWF2ZTNOdlpacVYtQlhEajNoQmttT28yVVNOOWI2YWh1cE5VeTlwRllZNHJlQU1zWG5NNjdWV0NHQWhoQnRnTlI0RFQyNVBJeTFLT014RjVkZS1rZVJpa2puNVhOdXZpTmxkeHl0eGxvRElNaHRZNnNzYkxIWWRlMWxieXZ5emFFOERaSmZlMFpOajNZYnBHc0E3Nmk5X3NwWkhNUHJKNWh3bVhYNlNB?oc=5","date":"2025-06-05","type":"regulatory","source":"Reuters","summary":"US Health Secretary Kennedy looks to fast-tracking approvals for rare disease drugs - Reuters","headline":"US Health Secretary Kennedy looks to fast-tracking approvals for rare disease drugs","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNMDRTZzIweHdhd184d2FvZEZzdEVTRm9xdFJfOU1UQjdlVUNXOXQ1cDBuTTd2TFBuY2QwY1pzNXJMNzQ2Qkd1NW1sTW84VHhKUDBzd1FRT0JiZmVXLXVTVWRoeXlhUEY4bDhGN3I0OGVjcko5a25JX1BqemNQcnAwU0VLTk8wYXZySGJmOFJSWXJNWUZ4Wks4?oc=5","date":"2025-04-17","type":"trial","source":"Kings Research","summary":"10 Best Innovators in the Rare Disease Clinical Trials Market - Kings Research","headline":"10 Best Innovators in the Rare Disease Clinical Trials Market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}